Calla Lily Clinical Care Ltd

DataGardener
live
Small

Calla Lily Clinical Care Ltd

13417472Private Limited With Share Capital

5Th Floor Charles House, 108-110 Finchley Road, London, NW35JJ
Incorporated

24/05/2021

Company Age

4 years

Directors

2

Employees

12

SIC Code

32500

Risk

low risk

Company Overview

Registration, classification & business activity

Calla Lily Clinical Care Ltd (13417472) is a private limited with share capital incorporated on 24/05/2021 (4 years old) and registered in london, NW35JJ. The company operates under SIC code 32500 - manufacture of medical and dental instruments and supplies.

Calla lily clinical care is a british medical device startup developing a leak-free, convenient and dosage-confident delivery platform for vaginally-delivered drugs. we are initially focused on delivering progesterone for miscarriage prevention and ivf, where there is an unmet need for a patient-fri...

Private Limited With Share Capital
SIC: 32500
Small
Incorporated 24/05/2021
NW35JJ
12 employees

Financial Overview

Total Assets

£1.74M

Liabilities

£69.7K

Net Assets

£1.67M

Cash

£753.5K

Key Metrics

12

Employees

2

Directors

78

Shareholders

1

Patents

Board of Directors

2

Filed Documents

34
Capital Allotment Shares
Category:Capital
Date:04-02-2026
Capital Allotment Shares
Category:Capital
Date:20-11-2025
Confirmation Statement With Updates
Category:Confirmation Statement
Date:03-06-2025
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:02-06-2025
Capital Allotment Shares
Category:Capital
Date:14-04-2025
Capital Allotment Shares
Category:Capital
Date:28-03-2025
Capital Allotment Shares
Category:Capital
Date:26-01-2025
Resolution
Category:Resolution
Date:06-01-2025
Memorandum Articles
Category:Incorporation
Date:06-01-2025
Statement Of Companys Objects
Category:Change Of Constitution
Date:30-12-2024
Change Registered Office Address Company With Date Old Address New Address
Category:Address
Date:30-12-2024
Capital Allotment Shares
Category:Capital
Date:20-12-2024
Confirmation Statement With Updates
Category:Confirmation Statement
Date:12-06-2024
Capital Allotment Shares
Category:Capital
Date:15-05-2024
Capital Allotment Shares
Category:Capital
Date:08-04-2024
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:20-03-2024
Capital Allotment Shares
Category:Capital
Date:09-01-2024
Capital Allotment Shares
Category:Capital
Date:09-01-2024
Appoint Person Director Company With Name Date
Category:Officers
Date:29-12-2023
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:29-05-2023
Confirmation Statement With Updates
Category:Confirmation Statement
Date:25-05-2023
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:12-01-2023
Change To A Person With Significant Control
Category:Persons With Significant Control
Date:03-01-2023
Capital Allotment Shares
Category:Capital
Date:03-01-2023
Notification Of A Person With Significant Control
Category:Persons With Significant Control
Date:18-10-2022
Cessation Of A Person With Significant Control
Category:Persons With Significant Control
Date:18-10-2022
Capital Allotment Shares
Category:Capital
Date:14-10-2022
Accounts With Accounts Type Total Exemption Full
Category:Accounts
Date:30-09-2022
Memorandum Articles
Category:Incorporation
Date:16-09-2022
Resolution
Category:Resolution
Date:16-09-2022
Statement Of Companys Objects
Category:Change Of Constitution
Date:12-09-2022
Confirmation Statement With No Updates
Category:Confirmation Statement
Date:01-07-2022
Change Account Reference Date Company Current Shortened
Category:Accounts
Date:25-11-2021
Incorporation Company
Category:Incorporation
Date:24-05-2021

Innovate Grants

2

This company received a grant of £698823.0 for Development Of A Women-Centric Gynaecological Drug Delivery Device To Improve Psychosocial And Physical Wellbeing During Treatment For Miscarriage & Pre-Term Birth Prevention, And Ivf. The project started on 01/04/2023 and ended on 31/03/2025.

This company received a grant of £349483.0 for Overcoming Pre-Clinical Challenges For A Next-Generation Gynaecological Drug Delivery Device Which Maximises Patient Comfort And Convenience. The project started on 01/11/2021 and ended on 31/10/2022.

Import / Export

Imports
12 Months2
60 Months7
Exports
12 Months2
60 Months2

Risk Assessment

low risk

International Score

Future Factor

good

Performance Rating

Accounts

Typetotal exemption full
Due Date30/09/2026
Filing Date02/06/2025
Latest Accounts31/12/2024

Trading Addresses

3Rd Floor, 86-90 Paul Street, London, EC2A4NE
5Th Floor Charles House, 108-110 Finchley Road, London, Nw3 5Jj, NW35JJRegistered

Related Companies

1

Contact

callali.ly
5Th Floor Charles House, 108-110 Finchley Road, London, NW35JJ